Filing Details

Accession Number:
0000950170-24-132401
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-02 19:50:40
Reporting Period:
2024-12-02
Accepted Time:
2024-12-02 19:50:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1815442 Kymera Therapeutics Inc. KYMR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744425 Pamela Esposito C/O Kymera Therapeutics, Inc.
500 North Beacon Street, 4Th Floor
Watertown MA 02472
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-02 2,500 $29.55 2,500 No 4 M Direct
Common Stock Disposition 2024-12-02 2,500 $49.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-12-02 2,500 $0.00 2,500 $29.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,127 2030-09-03 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person.
  2. The shares underlying this stock option are fully vested and exercisable.